Skip to content

A feasibility trial of hypnotic analgesia and cognitive hypnotherapy for chronic neuropathic pain with a single-case design

A feasibility trial of hypnotic analgesia and cognitive hypnotherapy for chronic neuropathic pain with a single-case design - J-POP study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052930
Enrollment
2
Registered
2024-04-01
Start date
2024-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Neuropathic Pain

Interventions

We offer the 4 sessions of hypnotic analgesia adding to treatment as usual as an intervention group no. 1. The following hypnotic suggestions are provided: (1) Decrease of unpleasant sensation, (2) Im

Sponsors

Kobe University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Having neuropathic pain. 2) Lasting neuropathic pain for at least 3 months. 3) Having a score of at least 3 points in the interview part of the DN4 Japanese version. 4) Having a score of at least 3 points on the Numerical Rating Scale measuring average pain in the last week. 5) Capable of continuing the current treatment's content as well as possible during the present trial. 6) Aged at least 18 years. 7) Having the ability to read, write, and speak Japanese. 8) Capable of obtaining written informed consent to participate in the present study based on the participants' free will. 9) Attending Shiga University of Medical Science Hospital.

Exclusion criteria

Exclusion criteria: 1) Currently receiving other psychotherapy. 2) Having experience receiving more than 4 sessions of hypnosis for pain treatment in the past. 3) Currently undergoing or planning to undergo new tests or treatments beyond the scope of usual care during the study period. 4) Cancer pain. 5) Complex regional pain syndrome type I. 6) Severe cognitive dysfunction. 7) Psychiatric problems that would preclude participation in the study now or in the past 6 months. 8) Pregnant. 9) Patients considered inappropriate to participate in the study by a doctor in charge.

Design outcomes

Primary

MeasureTime frame
Average pain intensity for the last 24 hours in the intervention and follow-up phases.

Secondary

MeasureTime frame
Maximum pain intensity for the last 24 hours. Average and maximum pain intensity for the last week. Pain interference, Psychological distress, Pain catastrophizing, Pain self-efficacy, Decentering, Readiness for pain self-management. All these outcomes will be evaluated in the intervention and follow-up phases.

Countries

Japan

Contacts

Public ContactTomonori Adachi

Kobe University Graduate School of Human Development and Environment

tadachi@people.kobe-u.ac.jp078-803-7905

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026